AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
APIXABAN TABLETS 5 MG
6 registrations across 3 African markets— 6 active
Markets with APIXABAN TABLETS 5 MG
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| APILTOX 5 Tablet, Filmcoated | 🇿🇲Zambia | BioMatrix Healthcare Private Limited | active | Apr 2031 |
| Axaban-Denk 5 mg Film Coated Tablets | 🇿🇲Zambia | Denk Pharma GmbH & Co. KG | active | Mar 2031 |
| Apigy 5 Tablet Uncoated | 🇿🇲Zambia | Cipla Ltd | active | Aug 2030 |
| INNOXAB 5 Film-coated Tablets | 🇿🇲Zambia | Innovata Pharmaceuticals (Pty) Ltd | active | Jul 2029 |
| APIZABAN 5 Film-Coated Tablet | 🇰🇪Kenya | AVETINA LIFE SCIENCES LTD | active | Mar 2028 |
| APIQX 5 Tablets | 🇹🇿Tanzania | Hetero Labs Limited | active | — |
APIXABAN TABLETS 5 MG in Africa — Regulatory Overview
APIXABAN TABLETS 5 MG is registered across 3 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Zambia, Kenya, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.
Of the 6 registrations, 6 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.